FDA Provides Emergency Use Authorization to PerkinElmer for COVID-19 Testing

Food and Healthcare Press Releases Thursday March 26, 2020 09:44
WALTHAM Mass.--26 Mar--PRNewswire/InfoQuest

PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, announced today that the U.S. Food and Drug Administration (FDA) has provided Emergency Use Authorization (EUA) for the Company's New Coronavirus RT-PCR test. Clinical laboratories certified under Clinical Laboratory Improvement Amendments (CLIA) can immediately begin using this kit to detect SARS-CoV-2, the virus that causes COVID-19. PerkinElmer's RT-PCR test is marketed as an in vitro diagnostic (IVD) device by meeting the requirements of the European In Vitro Diagnostic Directive (IVDD) and is available in over 30 countries worldwide.

"Despite the challenging environment, our employees have demonstrated unwavering commitment over the past two months to combat this global pandemic," said Prahlad Singh, president and chief executive officer, PerkinElmer. "The breadth of PerkinElmer's total workflow solution puts us in a unique position to rapidly address the needs of our clinical diagnostics customers."

About PerkinElmer

PerkinElmer enables scientists, researchers and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, we deliver unique solutions to serve the diagnostics, life sciences, food and applied markets. We strategically partner with customers to enable earlier and more accurate insights supported by deep market knowledge and technical expertise. Our dedicated team of about 13,000 employees worldwide is passionate about helping customers work to create healthier families, improve the quality of life, and sustain the wellbeing and longevity of people globally. The Company reported revenue of approximately $2.9 billion in 2019, serves customers in 190 countries, and is a component of the S&P 500 index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.

More information can be found on PerkinElmer's official website:
http://ir.perkinelmer.com/news-releases/news-release-details/fda-provides-emergency-use-authorization-perkinelmer-covid-19
Photo   https://photos.prnasia.com/prnh/20200325/2760526-1
Caption: PerkinElmer's New Coronavirus RT-PCR test

Latest Press Release

Prasat Neurological Institute joins with KBank to launch PNI PLUS app – an assistant for medical care in the 'New Normal’ era

Prasat Neurological Institute, Department of Medical Services, has partnered with KASIKORNBANK (KBank) to launch the PNI PLUS application and thus meet the lifestyle needs of the 'New Normal’ era. This innovative app gives patients improved access...

Xinhua Silk Road: Vegetarian capsule becomes new trend of international dietary supplement market in 2020

Vegetarian capsules are becoming a new trend in international dietary supplement market in 2020, as increasing health awareness has driven more consumers to natural product marketplace. Vegetarian capsules, both hard and soft shells, are made from...

Powerful and Proven: Community Health Workers Can Build Health and Equity During Pandemic & Beyond

New Orb Media reporting and data analysis of child mortality rates in 160 countries reveals the versatile and affordable role community health workers (CHWs) play in improving community health. New global model highlights surprising alternatives Orb...

miR Scientific Announces Validation of its Urine Based, Non-Invasive Prostate Cancer Test Published in the Journal of Urology

- Validated Data Reinforces Capability to Molecularly Detect and Characterize Prostate Cancer with Concurrent Sensitivity and Specificity of Over 91% - Data Support Integration of Sentinel Prostate Test(TM) in Patient Care Settings and...

PHC Holdings Corporation and Ascensia Diabetes Care Announce Financing Agreement and Exclusive Global Commercial Agreement With Senseonics

PHC Holdings Corporation and Ascensia Diabetes Care, a PHC Group company, today announced a strategic partnership with Senseonics Holdings, Inc., a medical technology company focused on the development and commercialization of long-term, implantable...

Related Topics